Skip to main content

Table 3 Risk for all-cause mortality by insurance status and access to care for individuals with albuminuria

From: Association between insurance status and mortality in individuals with albuminuria: an observational cohort study

 

All-cause mortality

P

CV mortality

P

N=

913

 

913

 

Unadjusted HR

 No Insurance V Private (REF)

1.30(0.77,2.21)

0.316

1.30(0.50,3.40)

0.581

 Public V Private

2.75(1.61,4.68)

<.001

2.30(1.12,4.72)

0.024

HR, Model 1a

 No Insurance V Private (REF)

1.80(0.74,4.34)

0.189

1.96(0.66,5.77)

0.219

 Public V Private

1.70(0.87,3.34)

0.118

1.73(0.63,4.76)

0.285

HR, Model 2b

 No Insurance V Private (REF)

1.86(0.71,4.87)

0.199

1.88(0.46,7.58)

0.370

 Public V Private

1.66(0.81,3.43)

0.165

1.48(0.47,4.65)

0.492

HR, Model 3c

 No Insurance V Private (REF)

1.90(0.83,4.34)

0.125

1.95(0.56,6.85)

0.288

 Public V Private

1.87(1.01,3.46)

0.046

1.57(0.52,4.73)

0.417

HR, Model 4d

 No Insurance V Private (REF)

2.97(1.29,6.85)

0.012

2.15(0.44,10.46)

0.337

 Public V Private

3.65(1.74,7.67)

<.001

3.21(0.77,13.43)

0.107

  1. aModel 1: Sociodemographic: age, gender, race/ethnicity, PIR (poverty income ratio), education, marital status
  2. bModel 2: Model 1+ Diabetes (Y/N), Cardiovascular disease (Y/N), smoking (Y/N), Body mass index, cancer (y/n)
  3. cModel 3: Model 2+ estimated glomerular filtration rate (eGFR), systolic blood pressure, cholesterol (<200 mg/dL, >200 mg/dL HgbA1c (<7, >7)
  4. dModel 4: Model 3 + statin(Y/N), angiotension converting enzyme (ACE)-Inhibitor (yes/no)